The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 5.52
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 1.48 (26.812%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 6.20
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Mining stocks pull FTSE 100 lower ahead of data

Thu, 12th Jun 2014 08:25

- Profit taking continues as miners fall- Traders await global economic data- Broker downgrades hit blue chipstechMARK 2,839.63 -0.04%FTSE 100 6,827.09 -0.17%FTSE 250 16,073.58 -0.09%UK stocks opened flat on Thursday morning as weakness in the mining sector held back any chances of a rebound.After coming within reach of a 14-year closing high earlier in the week, the FTSE 100 suffered a steep fall on Wednesday to finish at 6,838.87. Investors were looking to book profits with global equity indices trading at multi-year or record highs, while sentiment was dampened further after the World Bank downgraded its growth forecasts.Subdued risk appetite was keeping investors from 'buying on the dip' this morning as they awaited what is set to be a somewhat heavier session in terms of macro data. The FTSE 100 was 0.2% lower at 6,827 in early trading.Mike van Dulken, Head of Research at Accendo Markets, said that after the recent run on major bourses, traders are now "concerned about complacency and the emergence of fresh risks following a period of relative calm". Nevertheless, the FTSE 100 still remains range-bound with "catalysts lacking (for now) for a break either way", he said.After a quiet start to the week on the economic calendar, the focus today will turn to Eurozone industrial production, French inflation and US retail sales and jobless claims figures.Mining stocks fallMiners were among the worst performers this morning with Anglo American, BHP Billiton, Rio Tinto and Antofagasta falling sharply. Anglo was cut from 'equal weight' to 'underweight' at Morgan Stanley today.Shares in AstraZeneca rose after the pharmaceutical group signed a licence agreement with AIM-listed Synairgen for the development of SNG000l, a treatment for respiratory tract viral infections in patients with severe asthma.Natural gas producer BG Group was lower as it suffered from a ratings downgrade by Nomura to 'neutral'. Publisher Pearson was subdued after a Goldman Sachs downgrade to 'sell', while temporary power and temperature control group Aggreko was hit with a downgrade to 'sector performer' by RBC Capital Markets.In contrast, Provident Financial was on the rise after Citigroup lifted its recommendation on the stock to 'buy' and hiked its target price by nearly 38%.Infrastructure and construction peers Balfour Beatty, Galliford Try and Carillion all fell despite the news that they have been appointed as preferred bidders to work on a £745m project to build new roads in Scotland.Halma impressed with record annual revenue as the safety, health and environmental technology group achieved growth across all its sectors.Home improvement retailer Kingfisher edged lower after revealing that Philippe Tible, Chief Executive of its European Castorama & Brico Depot brands, will step down from the board at the end of July.FTSE 100 - RisersITV (ITV) 179.60p +1.70%Unilever (ULVR) 2,700.00p +0.82%AstraZeneca (AZN) 4,434.00p +0.77%British American Tobacco (BATS) 3,564.00p +0.59%Reckitt Benckiser Group (RB.) 5,155.00p +0.59%Lloyds Banking Group (LLOY) 79.51p +0.57%Imperial Tobacco Group (IMT) 2,640.00p +0.46%Diageo (DGE) 1,915.50p +0.45%Rolls-Royce Holdings (RR.) 1,021.00p +0.39%GlaxoSmithKline (GSK) 1,617.50p +0.37%FTSE 100 - FallersAnglo American (AAL) 1,410.50p -3.69%Rio Tinto (RIO) 3,093.00p -2.01%BHP Billiton (BLT) 1,856.50p -1.90%Aggreko (AGK) 1,628.00p -1.75%Sainsbury (J) (SBRY) 327.90p -1.53%International Consolidated Airlines Group SA (CDI) (IAG) 394.10p -1.48%Antofagasta (ANTO) 760.00p -1.23%Fresnillo (FRES) 783.50p -1.14%Glencore (GLEN) 320.60p -1.11%ARM Holdings (ARM) 898.00p -1.05%FTSE 250 - RisersOcado Group (OCDO) 380.00p +3.43%Provident Financial (PFG) 2,221.00p +2.26%Halma (HLMA) 602.50p +1.95%Partnership Assurance Group (PA.) 132.20p +1.85%Premier Farnell (PFL) 212.20p +1.82%Perform Group (PER) 274.50p +1.63%Fisher (James) & Sons (FSJ) 1,330.00p +1.53%Alent (ALNT) 335.00p +1.52%PayPoint (PAY) 1,131.00p +1.25%Infinis Energy (INFI) 211.60p +1.24%FTSE 250 - FallersAfren (AFR) 140.90p -2.29%Lonmin (LMI) 232.40p -1.82%Synthomer (SYNT) 244.97p -1.81%African Barrick Gold (ABG) 219.30p -1.75%Polymetal International (POLY) 545.50p -1.71%Evraz (EVR) 97.90p -1.66%Victrex plc (VCT) 1,737.00p -1.64%Ophir Energy (OPHR) 237.00p -1.62%Serco Group (SRP) 364.80p -1.33%Aveva Group (AVV) 2,217.00p -1.25%BC
More News
20 Jan 2021 21:16

IN BRIEF: Synairgen Recruits Covid-19 Patients Into Phase II Trial

IN BRIEF: Synairgen Recruits Covid-19 Patients Into Phase II Trial

Read more
13 Jan 2021 10:24

Synairgen Doses First Patient In Covid-19 Treatment Trial

Synairgen Doses First Patient In Covid-19 Treatment Trial

Read more
11 Jan 2021 20:54

COVID SCIENCE-COVID-19 patients still have symptoms 6 months later; interferon may be helpful treatment after all

By Nancy LapidJan 11 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.Half a year later, COVID-19 pat...

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 11:06

Synairgen Gets Fast Track Designation From US FDA For Covid-19 Vaccine

Synairgen Gets Fast Track Designation From US FDA For Covid-19 Vaccine

Read more
18 Dec 2020 10:29

Synairgen makes solid progress with Covid-19 treatment

(Sharecast News) - Respiratory drug development company Synairgen updated the market on its phase 3 trial design evaluating SNG001 as a treatment for patients with Covid-19 on Friday, as well as positive progress on its regulatory path.

Read more
18 Nov 2020 13:59

finnCap Interim Profit More Than Doubles; Chair To Step Down

finnCap Interim Profit More Than Doubles; Chair To Step Down

Read more
13 Nov 2020 14:28

Synairgen surges on positive results for Covid-19 treatment

(Sharecast News) - Synairgen shares surged on Friday after data from trials of its inhaled Covid-19 treatment, SNG001, published in The Lancet Respiratory Medicine, showed positive results in hospitalised patients.

Read more
13 Nov 2020 10:24

Synairgen Drug Helps Recovery In Hospitalised Covid-19 Patients

Synairgen Drug Helps Recovery In Hospitalised Covid-19 Patients

Read more
2 Nov 2020 20:03

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

Read more
15 Oct 2020 11:39

Synairgen Raises GBP80 Million In Placing, To Launch Open Offer

Synairgen Raises GBP80 Million In Placing, To Launch Open Offer

Read more
14 Oct 2020 18:02

IN BRIEF: Synairgen Looks To Raise GBP80 Million For SNG001 Trial

IN BRIEF: Synairgen Looks To Raise GBP80 Million For SNG001 Trial

Read more
29 Sep 2020 12:14

Synairgen Progresses Covid-19 Treatment As Expenses Increase

Synairgen Progresses Covid-19 Treatment As Expenses Increase

Read more
9 Sep 2020 16:04

IN BRIEF: Synairgen Makes Inhaled Interferon Beta Patent Application

IN BRIEF: Synairgen Makes Inhaled Interferon Beta Patent Application

Read more
9 Sep 2020 12:23

Synairgen files for another patent on 'SNG001'

(Sharecast News) - Respiratory drug development company Synairgen updated the market on its intellectual property for the wholly-owned inhaled interferon beta asset 'SNG001' on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.